What does CUSIP 00650F109 represent in this 13F holders report?

CUSIP 00650F109 is the security identifier for ADPT - Adaptive Biotechnologies Corp - Common Stock used to aggregate holder disclosures.

How many institutions held ADPT - Adaptive Biotechnologies Corp - Common Stock in Q2 2019?

110 institutional investors reported ADPT - Adaptive Biotechnologies Corp - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 151,803,139
Total 13F shares: 78,228,081
Share change: +78,124,140
Total reported value: $3,735,247,853
Price per share: $48.30
Number of holders: 110
Value change: +$3,731,000,860
Number of buys: 109

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 00650F109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ADPT - Adaptive Biotechnologies Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CWM, LLC	13F	Company	0.07%	103,941	$4,247,000	—	31 Mar 2019	13F

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q2 2019

As of 30 Jun 2019, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 110 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 78,228,081 shares. The largest 10 holders included Viking Global Investors LP, Matrix Capital Management Company, LP, Senator Investment Group LP, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., BAMCO INC /NY/, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, and FMR LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Q2 2019 holders

110

Holder diff

109

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.